Evidence map›Paper›PMID 29458351›Full record

ArticleBMC bioinformatics2018

CEMiTool: a Bioconductor package for performing comprehensive modular co-expression analyses.

Pedro S T Russo, Gustavo R Ferreira, Lucas E Cardozo, Matheus C Bürger, Raul Arias-Carrasco, Sandra R Maruyama, Thiago D C Hirata, Diógenes S Lima, Fernando M Passos, Kiyoshi F Fukutani and 4 more

Abstract read
In one paragraph

Article in BMC bioinformatics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 175 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
175citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

175 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Doxycycline host-directed therapy in human pulmonary tuberculosis.The Journal of clinical investigation · 2021
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Metabolic Imaging and Molecular Signatures Reveal Metabolic Phenotypes in Recurrent Glioblastoma.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Transcription-based comparison ofMicrobiology spectrum · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Inflammatory Biomarkers of Asymptomatic and Symptomatic Tuberculosis.bioRxiv : the preprint server for biology · 2025
    Article

115 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Pedro S T RussoDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, 05508-900, Brazil.
Gustavo R FerreiraDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, 05508-900, Brazil.
Lucas E CardozoDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, 05508-900, Brazil.
Matheus C BürgerDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, 05508-900, Brazil.
Raul Arias-CarrascoAdvanced Center for Chronic Diseases (ACCDiS), Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago, Chile.
Sandra R MaruyamaDepartment of Biochemistry, Immunology, and Cell Biology, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
Thiago D C HirataDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, 05508-900, Brazil.
Diógenes S LimaDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, 05508-900, Brazil.
Fernando M PassosDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, 05508-900, Brazil.
Kiyoshi F FukutaniDepartment of Biochemistry, Immunology, and Cell Biology, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
Melissa LeverDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, 05508-900, Brazil.
João S SilvaDepartment of Biochemistry, Immunology, and Cell Biology, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
Vinicius Maracaja-CoutinhoAdvanced Center for Chronic Diseases (ACCDiS), Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago, Chile.
Helder I NakayaDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, 05508-900, Brazil. hnakaya@usp.br.

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 305985/2014-0Conselho Nacional de Desenvolvimento Científico e Tecnológico 443719/2014-4Fundação de Amparo à Pesquisa do Estado de São Paulo 2012/19278-6Fundação de Amparo à Pesquisa do Estado de São Paulo 2013/08216-2
6 · The paper itself

Abstract

backgroundThe analysis of modular gene co-expression networks is a well-established method commonly used for discovering the systems-level functionality of genes. In addition, these studies provide a basis for the discovery of clinically relevant molecular pathways underlying different diseases and conditions.

resultsIn this paper, we present a fast and easy-to-use Bioconductor package named CEMiTool that unifies the discovery and the analysis of co-expression modules. Using the same real datasets, we demonstrate that CEMiTool outperforms existing tools, and provides unique results in a user-friendly html report with high quality graphs. Among its features, our tool evaluates whether modules contain genes that are over-represented by specific pathways or that are altered in a specific sample group, as well as it integrates transcriptomic data with interactome information, identifying the potential hubs on each network. We successfully applied CEMiTool to over 1000 transcriptome datasets, and to a new RNA-seq dataset of patients infected with Leishmania, revealing novel insights of the disease's physiopathology.

conclusionThe CEMiTool R package provides users with an easy-to-use method to automatically implement gene co-expression network analyses, obtain key information about the discovered gene modules using additional downstream analyses and retrieve publication-ready results via a high-quality interactive report.

Indexed as

Gene Expression RegulationGene Regulatory NetworksSoftwareAutomationDatabases, GeneticDengueGene Expression ProfilingHumansLeishmaniasis, VisceralPsoriasisSequence Analysis, RNATranscriptomeCo-expression modulesGene networksLeishmaniasisModular analysisTranscriptomics

Identifiers

PMID29458351
PMCPMC5819234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.